Amicus Therapeutics (FOLD) Misses Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Total operating expenses: 46.72M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 46.72M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.18), $0.04 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $86.3 million versus the consensus estimate of $83.07 million.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
- Citi raises Deere price target to $650, keeps Neutral rating
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
